Near-Infrared Imaging Market - Global Forecast to 2030
商品番号 : SMB-37428
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年8月 |
| ページ数 | 289 |
| 図表数 | 328 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、近赤外線イメージング市場を製品、手順、用途、エンドユーザー、地域の観点から分析しています。市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーの競争環境の詳細を提供しています。さらに、ミクロ市場を個々の成長傾向の観点から分析しています。5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。
本レポートは、既存企業だけでなく新規参入企業や小規模企業も市場の動向を把握し、市場シェアの拡大に役立てることができます。本レポートを購入した企業は、以下の戦略のいずれか、または組み合わせて活用することで、市場でのプレゼンスを強化できます。
世界の近赤外線イメージング市場は、2025年の12億8,000万米ドルから2030年には19億9,000万米ドルに達し、予測期間中は年平均成長率（CAGR）9.3%で成長すると予測されています。手術誘導や分子イメージングのためのハイブリッド近赤外線イメージングモダリティの導入、近赤外線イメージングモダリティの技術進歩、そして世界的な外科手術件数の増加は、予測期間における市場成長を後押しする主な要因と予想されます。さらに、従来の可視化手法に対する近赤外線イメージングの利点も、近赤外線イメージングの需要増加に大きく貢献する要因となっています。
The global near IR imaging market is projected to reach USD 1.99 billion by 2030 from USD 1.28 billion in 2025, at a CAGR of 9.3% during the forecast period. The adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging, technological advancements in near-infrared imaging modalities, and the increasing number of surgical procedures globally are major factors anticipated to boost market growth in the forecasting years. Additionally, the advantages of near-infrared imaging over conventional visualization methods also pose as a factor that contributes enormously to the increase in demand for near-infrared imaging.
By procedure, the gastrointestinal surgeries segment accounted for the largest share of the market in 2024.
Based on procedure, the near-infrared imaging market is segmented into gastrointestinal surgeries, plastic/reconstructive surgeries, cancer surgeries, obstetrics & gynecology surgeries, cardiovascular surgeries, and other procedures. The gastrointestinal surgeries segment is further segmented into colorectal surgeries and other gastrointestinal surgeries. The rising incidence of gastrointestinal diseases such as colorectal cancer, Crohn’s disease, ulcerative colitis, and gastric tumors significantly increases the need for surgical interventions, which is expected to fuel the demand for columns in the studied period.
By application, the clinical imaging segment accounted for the largest market share in 2024.
By application, the market is segmented into medical imaging, preclinical imaging, and clinical imaging. The clinical imaging segment accounted for the largest share of the market in 2024. The growth of this segment can be attributed to the increasing adoption of this imaging modality owing to the advantages offered by this technique and advancements in fluorescence imaging for clinical applications.
The Asia Pacific region is expected to register the highest growth rate during the forecast period.
By region, the near-infrared imaging market covers North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is estimated to register the highest growth rate during the forecast period. The presence of a large patient population, a rising geriatric population, and a huge population base for cancer and cardiovascular disease will fuel growth in this region during the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1– 48%, Tier 2– 36%, and Tier 3– 16%
- By Designation: Directors– 14%, C-level– 10%, and Others– 76%
- By Region: North America– 40%, Europe– 32%, Asia Pacific– 20%, Latin America- 5%, Middle East & Africa- 3%
The prominent players in the near infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US), LI-COR Biotech (US), Hamamatsu Photonics K.K. (Japan), Quest Medical Imaging B.V. (Netherlands), Merck KGaA (Germany), MIZUHO Corporation (Japan), Teledyne Princeton Instruments (US), Thermo Fisher Scientific Inc. (US), FLUOPTICS SAS (Getinge, France), Medtronic (Ireland), Cayman Chemical (US), MP Biomedicals (US), Crysta-LYN Chemical Company (US), and Gowerlabs Ltd. (UK), among others.
Research Coverage
This report studies the near-infrared imaging market based on product, procedure, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (Increasing number of surgical procedures globally, advantages of near-infrared imaging over conventional visualization methods, technological advancements in near-infrared imaging modalities, adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging), restraints (Lengthy approval process for near-infrared fluorophores, high initial capital and operational costs of near-infrared systems, availability of alternate technologies), opportunities (Growth potential in emerging economies, use of blockchain for distribution and storage of medical images), and challenges (Hospital budget cuts, dearth of trained professionals in emerging economies) influencing the growth of the near infrared imaging market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the near-infrared imaging market
- Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the near-infrared imaging market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the near-infrared imaging market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 STUDY SCOPE 29
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 29
1.3.2 INCLUSIONS & EXCLUSIONS 30
1.3.3 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 31
1.5 MARKET STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA SOURCES 34
2.1.1 SECONDARY DATA 35
2.1.1.1 List of secondary sources 35
2.1.2 PRIMARY DATA SOURCES 36
2.1.2.1 List of key primary stakeholders interviewed 36
2.1.2.2 Insights from primary experts 37
2.2 MARKET ESTIMATION METHODOLOGY 39
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 40
2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 41
2.3 MARKET FORECASTING 42
2.4 PRIMARY RESEARCH VALIDATION 43
2.5 DATA TRIANGULATION & MARKET BREAKDOWN 44
2.6 RESEARCH ASSUMPTIONS 45
2.6.1 STUDY ASSUMPTIONS 45
2.7 RESEARCH LIMITATIONS 45
2.8 RISK ASSESSMENT 46
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 52
4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW 52
4.2 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT AND COUNTRY (2024) 53
4.3 NEAR-INFRARED IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
4.4 NEAR-INFRARED IMAGING MARKET: REGIONAL MIX, 2023–2030 (USD MILLION) 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
5.2.1 DRIVERS 57
5.2.1.1 Increasing number of surgical procedures globally 57
5.2.1.2 Advantages of near-infrared imaging over conventional visualization methods 58
5.2.1.3 Technological advancements in near-infrared imaging modalities 58
5.2.1.4 Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging 59
5.2.2 RESTRAINTS 59
5.2.2.1 Lengthy approval process of near-infrared fluorophores 59
5.2.2.2 High initial capital and operational costs of near-infrared systems 60
5.2.2.3 Availability of alternate technologies 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Growth potential for major players in emerging economies 60
5.2.3.2 Use of blockchain for distribution and storage of medical images 61
5.2.4 CHALLENGES 61
5.2.4.1 Hospital budget cuts 61
5.2.4.2 Dearth of trained professionals in emerging economies 62
5.3 REGULATORY ANALYSIS 63
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
5.3.2 REGULATORY LANDSCAPE 65
5.3.2.1 North America 65
5.3.2.1.1 US 65
5.3.2.1.2 Canada 67
5.3.2.2 Europe 67
5.3.2.3 Asia Pacific 68
5.3.2.3.1 Japan 68
5.3.2.3.2 China 69
5.3.2.3.3 India 70
5.3.2.4 Middle East (GCC Region) 70
5.3.2.4.1 UAE 70
5.3.2.4.2 Saudi Arabia 70
5.3.2.5 Africa 71
5.4 REIMBURSEMENT ANALYSIS 71
5.5 VALUE CHAIN ANALYSIS 72
5.5.1 RESEARCH & DEVELOPMENT 72
5.5.2 PROCUREMENT & PRODUCT DEVELOPMENT 72
5.5.3 MARKETING, SALES, AND DISTRIBUTION 72
5.6 SUPPLY CHAIN ANALYSIS 73
5.6.1 PROMINENT COMPANIES 73
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES 73
5.6.3 END USERS 74
5.7 ECOSYSTEM ANALYSIS 74
5.8 PORTER’S FIVE FORCES ANALYSIS 76
5.8.1 INTENSITY OF COMPETITIVE RIVALRY 77
5.8.2 BARGAINING POWER OF SUPPLIERS 77
5.8.3 BARGAINING POWER OF BUYERS 77
5.8.4 THREAT OF SUBSTITUTES 77
5.8.5 THREAT OF NEW ENTRANTS 78
5.9 KEY STAKEHOLDERS & BUYING CRITERIA 78
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 78
5.9.2 KEY BUYING CRITERIA 79
5.10 TRADE ANALYSIS 80
5.10.1 IMPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750) 80
5.10.2 EXPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750) 81
5.11 PATENT ANALYSIS 82
5.12 PRICING ANALYSIS 85
5.12.1 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY TYPE 85
5.12.2 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS,
BY KEY PLAYER 86
5.12.3 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS,
BY REGION 87
5.13 TECHNOLOGY ANALYSIS 89
5.13.1 KEY TECHNOLOGIES 89
5.13.1.1 InGaAs (Indium Gallium Arsenide) detectors 89
5.13.1.2 CMOS sensors 90
5.13.1.3 Hyperspectral imaging 90
5.13.2 COMPLEMENTARY TECHNOLOGIES 90
5.13.2.1 Image processing software 90
5.13.2.2 Optical coherence tomography (OCT) 90
5.13.2.3 Raman spectroscopy 91
5.13.3 ADJACENT TECHNOLOGIES 91
5.13.3.1 SWIR (short-wave infrared) imaging 91
5.13.3.2 Thermal imaging 91
5.13.3.3 UV-VIS-NIR spectroscopy 91
5.14 CASE STUDY ANALYSIS 92
5.14.1 TECHNOLOGICAL CHALLENGES 92
5.14.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING 93
5.15 KEY CONFERENCES & EVENTS, 2025–2026 93
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
5.17 INVESTMENT & FUNDING SCENARIO 95
5.18 UNMET NEEDS ANALYSIS 96
5.19 IMPACT OF GENERATIVE AI ON NEAR-INFRARED IMAGING MARKET 97
5.20 IMPACT OF 2025 US TARIFFS ON NEAR-INFRARED IMAGING MARKET 98
5.20.1 KEY TARIFF RATES 99
5.20.2 PRICE IMPACT ANALYSIS 100
5.20.3 PRICE IMPACT ON COUNTRY/REGION 100
5.20.3.1 US 100
5.20.3.2 Europe 101
5.20.3.3 Asia Pacific 101
5.20.4 IMPACT ON COUNTRY/REGION 101
5.20.4.1 US 101
5.20.4.2 Europe 101
5.20.4.3 Asia Pacific 102
5.20.5 IMPACT ON END-USE INDUSTRIES 102
6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT 103
6.1 INTRODUCTION 104
6.2 DEVICES 104
6.2.1 FLUORESCENCE IMAGING SYSTEMS 107
6.2.1.1 Higher sensitivity and better real-time image guidance during surgeries to drive market 107
6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS 108
6.2.2.1 Better sensitivity and higher efficiency at lower costs to drive market 108
6.3 AGENTS/PROBES 109
6.3.1 INDOCYANINE GREEN 112
6.3.1.1 Increasing utilization of small organic probes in near-infrared imaging to drive segmental growth 112
6.3.2 OTHER REAGENTS 113
6.4 DYES 113
6.4.1 ORGANIC DYES 116
6.4.1.1 Unique molecular structure and better compatibility with biological systems to support market growth 116
6.4.2 NANOPARTICLE DYES 117
6.4.2.1 Better brightness and enhanced signal intensity compared to organic dyes to boost adoption 117
7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE 118
7.1 INTRODUCTION 119
7.2 CANCER SURGERIES 119
7.2.1 BRAIN CANCER/TUMOR SURGERIES 121
7.2.1.1 Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market growth 121
7.2.2 OTHER CANCER SURGERIES 122
7.3 GASTROINTESTINAL SURGERIES 122
7.3.1 COLORECTAL SURGERIES 124
7.3.1.1 Advancements in treatment strategies and procedures to support market growth 124
7.3.2 OTHER GASTROINTESTINAL SURGERIES 125
7.4 CARDIOVASCULAR SURGERIES 126
7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET GROWTH 126
7.5 PLASTIC/RECONSTRUCTIVE SURGERIES 127
7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO BOOST MARKET 127
7.6 OBSTETRICS & GYNECOLOGY SURGERIES 129
7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO CONTRIBUTE TO GROWTH 129
7.7 OTHER PROCEDURES 130
8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION 131
8.1 INTRODUCTION 132
8.2 PRECLINICAL IMAGING 132
8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET 132
8.3 CLINICAL IMAGING 133
8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO FUEL GROWTH 133
8.4 MEDICAL IMAGING 134
8.4.1 GROWING APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET 134
9 NEAR-INFRARED IMAGING MARKET, BY END USER 136
9.1 INTRODUCTION 137
9.2 HOSPITALS & SURGICAL CLINICS 137
9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET GROWTH 137
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 138
9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO BOOST GROWTH 138
9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 139
9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH 139
9.5 OTHER END USERS 141
10 NEAR-INFRARED IMAGING MARKET, BY REGION 142
10.1 INTRODUCTION 143
10.2 NORTH AMERICA 143
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 143
10.2.2 US 148
10.2.2.1 Advanced healthcare infrastructure and favorable regulations to drive market 148
10.2.3 CANADA 150
10.2.3.1 Increased availability of research funding to drive market 150
10.3 EUROPE 152
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 152
10.3.2 GERMANY 157
10.3.2.1 Increasing healthcare expenditure and government spending to drive market growth 157
10.3.3 FRANCE 159
10.3.3.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to boost market 159
10.3.4 UK 161
10.3.4.1 Growing government initiatives and increasing incidence of chronic diseases to support growth 161
10.3.5 ITALY 164
10.3.5.1 Increased availability of reimbursement coverage for diagnostic procedures to fuel growth 164
10.3.6 SPAIN 165
10.3.6.1 Increasing prevalence of cancer and growing private-public funding to propel growth 165
10.3.7 REST OF EUROPE 167
10.4 ASIA PACIFIC 169
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 169
10.4.2 CHINA 175
10.4.2.1 Increasing healthcare reforms and government investments to drive market 175
10.4.3 JAPAN 177
10.4.3.1 Fast adoption of advanced technologies and growth in geriatric population to boost market 177
10.4.4 INDIA 179
10.4.4.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market 179
10.4.5 AUSTRALIA 181
10.4.5.1 Growing healthcare spending and increasing investments in research to fuel growth 181
10.4.6 SOUTH KOREA 183
10.4.6.1 Presence of advanced healthcare system and increased awareness about diseases to contribute to growth 183
10.4.7 REST OF ASIA PACIFIC 185
10.5 LATIN AMERICA 187
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 187
10.5.2 BRAZIL 192
10.5.2.1 Greater purchasing power and more favorable demographic conditions to boost growth 192
10.5.3 MEXICO 193
10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market 193
10.5.4 REST OF LATIN AMERICA 195
10.6 MIDDLE EAST & AFRICA 197
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 197
10.6.2 GCC COUNTRIES 202
10.6.2.1 Supportive government initiatives to aid market growth 202
10.6.3 REST OF MIDDLE EAST & AFRICA 204
11 COMPETITIVE LANDSCAPE 206
11.1 OVERVIEW 206
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 206
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET 206
11.3 REVENUE ANALYSIS, 2020−2024 208
11.4 MARKET SHARE ANALYSIS, 2024 208
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 210
11.5.1 STARS 210
11.5.2 EMERGING LEADERS 211
11.5.3 PERVASIVE PLAYERS 211
11.5.4 PARTICIPANTS 211
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 213
11.5.5.1 Company footprint 213
11.5.5.2 Region footprint 214
11.5.5.3 Product footprint 215
11.5.5.4 Procedure footprint 216
11.5.5.5 Application footprint 217
11.5.5.6 End-user footprint 218
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 219
11.6.1 PROGRESSIVE COMPANIES 219
11.6.2 RESPONSIVE COMPANIES 219
11.6.3 DYNAMIC COMPANIES 219
11.6.4 STARTING BLOCKS 219
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 221
11.6.5.1 Detailed list of key startups/SMEs 221
11.6.5.2 Competitive benchmarking of key emerging players/startups 222
11.7 COMPANY VALUATION & FINANCIAL METRICS 223
11.7.1 FINANCIAL METRICS 223
11.7.2 COMPANY VALUATION 223
11.8 BRAND/PRODUCT COMPARISON 224
11.9 COMPETITIVE SCENARIO 225
11.9.1 PRODUCT LAUNCHES 225
11.9.2 DEALS 226
11.9.3 EXPANSIONS 227
12 COMPANY PROFILES 228
12.1 KEY PLAYERS 228
12.1.1 STRYKER 228
12.1.1.1 Business overview 228
12.1.1.2 Products offered 229
12.1.1.3 Recent developments 230
12.1.1.3.1 Product launches 230
12.1.1.3.2 Deals 231
12.1.1.4 MnM view 231
12.1.1.4.1 Right to win 231
12.1.1.4.2 Strategic choices 231
12.1.1.4.3 Weaknesses & competitive threats 231
12.1.2 CARL ZEISS MEDITEC AG 232
12.1.2.1 Business overview 232
12.1.2.2 Products offered 233
12.1.2.3 Recent developments 234
12.1.2.3.1 Product launches 234
12.1.2.3.2 Deals 234
12.1.2.3.3 Expansions 234
12.1.2.4 MnM view 235
12.1.2.4.1 Right to win 235
12.1.2.4.2 Strategic choices 235
12.1.2.4.3 Weaknesses & competitive threats 235
12.1.3 PERKINELMER, INC. 236
12.1.3.1 Business overview 236
12.1.3.2 Products offered 236
12.1.3.3 Recent developments 237
12.1.3.3.1 Expansions 237
12.1.4 OLYMPUS CORPORATION 238
12.1.4.1 Business overview 238
12.1.4.2 Products offered 239
12.1.4.3 Recent developments 240
12.1.4.3.1 Product launches 240
12.1.4.3.2 Deals 240
12.1.4.3.3 Expansions 240
12.1.4.4 MnM view 241
12.1.4.4.1 Right to win 241
12.1.4.4.2 Strategic choices 241
12.1.4.4.3 Weaknesses & competitive threats 241
12.1.5 LEICA MICROSYSTEMS 242
12.1.5.1 Business overview 242
12.1.5.2 Products offered 243
12.1.5.3 Recent developments 244
12.1.5.3.1 Deals 244
12.1.5.3.2 Expansions 244
12.1.5.4 MnM view 244
12.1.5.4.1 Right to win 244
12.1.5.4.2 Strategic choices 244
12.1.5.4.3 Weaknesses & competitive threats 245
12.1.6 KARL STORZ SE & CO. KG 246
12.1.6.1 Business overview 246
12.1.6.2 Products offered 246
12.1.6.3 MnM view 247
12.1.6.3.1 Right to win 247
12.1.6.3.2 Strategic choices 247
12.1.6.3.3 Weaknesses & competitive threats 247
12.1.7 SHIMADZU CORPORATION 248
12.1.7.1 Business overview 248
12.1.7.2 Products offered 249
12.1.7.3 Recent developments 250
12.1.7.3.1 Product launches 250
12.1.7.3.2 Deals 250
12.1.7.3.3 Expansions 250
12.1.8 LI-COR BIOTECH, LLC 251
12.1.8.1 Business overview 251
12.1.8.2 Products offered 251
12.1.8.3 Recent developments 252
12.1.8.3.1 Product launches 252
12.1.9 HAMAMATSU PHOTONICS K.K. 253
12.1.9.1 Business overview 253
12.1.9.2 Products offered 254
12.1.9.3 Recent developments 255
12.1.9.3.1 Expansions 255
12.1.10 QUEST MEDICAL IMAGING B.V. 256
12.1.10.1 Business overview 256
12.1.10.2 Products offered 256
12.1.11 MERCK KGAA (SIGMA-ALDRICH) 257
12.1.11.1 Business overview 257
12.1.11.2 Products offered 258
12.1.11.3 Recent developments 259
12.1.11.3.1 Expansions 259
12.1.12 MIZUHO MEDICAL CO., LTD. 260
12.1.12.1 Business overview 260
12.1.12.2 Products offered 260
12.1.13 TELEDYNE PRINCETON INSTRUMENTS 261
12.1.13.1 Business overview 261
12.1.13.2 Products offered 262
12.1.14 THERMO FISHER SCIENTIFIC INC. 263
12.1.14.1 Business overview 263
12.1.14.2 Products offered 264
12.1.15 FLUOPTICS SAS (PART OF GETINGE) 265
12.1.15.1 Business overview 265
12.1.15.2 Products offered 265
12.1.16 MEDTRONIC 266
12.1.16.1 Business overview 266
12.1.16.2 Products offered 266
12.1.17 CAYMAN CHEMICAL 267
12.1.17.1 Business overview 267
12.1.17.2 Products offered 267
12.1.18 MP BIOMEDICALS 268
12.1.18.1 Business overview 268
12.1.18.2 Products offered 268
12.1.19 CRYSTA-LYN CHEMICAL COMPANY 269
12.1.19.1 Business overview 269
12.1.19.2 Products offered 269
12.1.20 GOWERLABS LTD. 270
12.1.20.1 Business overview 270
12.1.20.2 Products offered 270
12.2 OTHER PLAYERS 271
12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC 271
12.2.2 EXOSENS (XENICS NV) 272
12.2.3 BIOTIUM 273
12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD. 274
12.2.5 AAT BIOQUEST, INC. 275
12.2.6 OXFORD INSTRUMENTS 276
12.2.7 MOTHERSON 277
12.2.8 PHOTON ETC 278
12.2.9 SOTERIX MEDICAL INC. 279
12.2.10 KERNEL 280
13 APPENDIX 281
13.1 DISCUSSION GUIDE 281
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 285
13.3 CUSTOMIZATION OPTIONS 287
13.4 RELATED REPORTS 287
13.5 AUTHOR DETAILS 288
LIST OF TABLES
TABLE 1 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS 58
TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
TABLE 3 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 4 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 64
TABLE 5 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 64
TABLE 6 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 65
TABLE 7 US: APPROVED IMAGING DEVICES BY FDA 65
TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION 66
TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 66
TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 68
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 69
TABLE 13 MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES
IN US (2025) 71
TABLE 14 NEAR-INFRARED IMAGING MARKET: ROLE IN ECOSYSTEM 75
TABLE 15 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 76
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEAR-INFRARED IMAGING PRODUCTS 79
TABLE 17 KEY BUYING CRITERIA FOR NEAR-INFRARED IMAGING PRODUCTS 79
TABLE 18 IMPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750),
BY COUNTRY, 2020−2024 (USD) 80
TABLE 19 EXPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750),
BY COUNTRY, 2020−2024 (USD) 81
TABLE 20 AVERAGE SELLING PRICE OF TOP NIR PRODUCTS, BY KEY PLAYER, 2024 (USD) 86
TABLE 21 AVERAGE SELLING PRICE TREND OF NEAR-INFRARED IMAGING PRODUCTS,
BY REGION, 2022–2024 87
TABLE 22 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 92
TABLE 23 CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING
UP WITH EVOLVING SURGICAL TECHNIQUES 93
TABLE 24 NEAR-INFRARED IMAGING MARKET: DETAILED LIST OF MAJOR
CONFERENCES & EVENTS 93
TABLE 25 NEAR-INFRARED IMAGING MARKET: CURRENT UNMET NEEDS 96
TABLE 26 US-ADJUSTED RECIPROCAL TARIFF RATES (AS OF AUGUST, 2025) 99
TABLE 27 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 104
TABLE 28 NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 104
TABLE 29 NEAR-INFRARED IMAGING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 30 NEAR-INFRARED IMAGING DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 105
TABLE 31 NEAR-INFRARED IMAGING DEVICES MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 106
TABLE 32 NEAR-INFRARED IMAGING DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 106
TABLE 33 NEAR-INFRARED IMAGING DEVICES MARKET FOR FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 108
TABLE 34 NEAR-INFRARED IMAGING DEVICES MARKET FOR FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 35 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 110
TABLE 36 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 37 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 110
TABLE 38 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 111
TABLE 39 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY END USER,
2023–2030 (USD MILLION) 111
TABLE 40 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET FOR INDOCYANINE GREEN, BY REGION, 2023–2030 (USD MILLION) 112
TABLE 41 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET FOR OTHER REAGENTS,
BY REGION, 2023–2030 (USD MILLION) 113
TABLE 42 NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 114
TABLE 43 NEAR-INFRARED IMAGING DYES MARKET, BY REGION, 2023–2030 (USD MILLION) 114
TABLE 44 NEAR-INFRARED IMAGING DYES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 114
TABLE 45 NEAR-INFRARED IMAGING DYES MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 115
TABLE 46 NEAR-INFRARED IMAGING DYES MARKET, BY END USER,
2023–2030 (USD MILLION) 115
TABLE 47 NEAR-INFRARED IMAGING DYES MARKET FOR ORGANIC DYES, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 48 NEAR-INFRARED IMAGING DYES MARKET FOR NANOPARTICLE DYES,
BY REGION, 2023–2030 (USD MILLION) 117
TABLE 49 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 119
TABLE 50 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE,
2023–2030 (USD MILLION) 120
TABLE 51 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION,
2023–2030 (USD MILLION) 120
TABLE 52 NEAR-INFRARED IMAGING MARKET FOR BRAIN CANCER/TUMOR SURGERIES,
BY REGION, 2023–2030 (USD MILLION) 121
TABLE 53 NEAR-INFRARED IMAGING MARKET FOR OTHER CANCER SURGERIES,
BY REGION, 2023–2030 (USD MILLION) 122
TABLE 54 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES,
BY TYPE, 2023–2030 (USD MILLION) 123
TABLE 55 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES,
BY REGION, 2023–2030 (USD MILLION) 124
TABLE 56 NEAR-INFRARED IMAGING MARKET FOR COLORECTAL SURGERIES, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 57 NEAR-INFRARED IMAGING MARKET FOR OTHER GASTROINTESTINAL SURGERIES, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 58 NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR SURGERIES,
BY REGION, 2023–2030 (USD MILLION) 127
TABLE 59 NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 60 NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2023–2030 (USD MILLION) 129
TABLE 61 NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION,
2023–2030 (USD MILLION) 130
TABLE 62 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 132
TABLE 63 NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 133
TABLE 64 NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 134
TABLE 65 NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 135
TABLE 66 NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 137
TABLE 67 NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS,
BY REGION, 2023–2030 (USD MILLION) 138
TABLE 68 NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 69 NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 140
TABLE 70 NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 141
TABLE 71 NEAR-INFRARED IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 72 NORTH AMERICA: KEY MACROINDICATORS 144
TABLE 73 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 145
TABLE 74 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 145
TABLE 75 NORTH AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 146
TABLE 76 NORTH AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 77 NORTH AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 146
TABLE 78 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 147
TABLE 79 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 147
TABLE 80 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 148
TABLE 81 US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 149
TABLE 82 US: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 149
TABLE 83 US: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 150
TABLE 84 US: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 150
TABLE 85 CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 151
TABLE 86 CANADA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 151
TABLE 87 CANADA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 152
TABLE 88 CANADA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 152
TABLE 89 EUROPE: KEY MACROINDICATORS 153
TABLE 90 EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 91 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 154
TABLE 92 EUROPE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 154
TABLE 93 EUROPE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 154
TABLE 94 EUROPE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 155
TABLE 95 EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 155
TABLE 96 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 156
TABLE 97 EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 156
TABLE 98 GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 157
TABLE 99 GERMANY: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 100 GERMANY: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 101 GERMANY: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 102 FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 159
TABLE 103 FRANCE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 104 FRANCE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 105 FRANCE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 106 UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161
TABLE 107 UK: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 161
TABLE 108 UK: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 109 UK: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 110 UK: NUMBER OF FLUOROSCOPY IMAGING ACTIVITIES, 2012–2024 163
TABLE 111 ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 164
TABLE 112 ITALY: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 164
TABLE 113 ITALY: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 114 ITALY: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 165
TABLE 115 SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 166
TABLE 116 SPAIN: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 166
TABLE 117 SPAIN: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 118 SPAIN: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 119 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 168
TABLE 120 REST OF EUROPE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 168
TABLE 121 REST OF EUROPE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 122 REST OF EUROPE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 123 ASIA PACIFIC: MACROECONOMIC INDICATORS 170
TABLE 124 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 172
TABLE 125 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 172
TABLE 126 ASIA PACIFIC: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 127 ASIA PACIFIC: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 128 ASIA PACIFIC: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 129 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 174
TABLE 130 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 174
TABLE 131 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 175
TABLE 132 CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 176
TABLE 133 CHINA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 176
TABLE 134 CHINA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 135 CHINA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 136 JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 178
TABLE 137 JAPAN: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 138 JAPAN: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 179
TABLE 139 JAPAN: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 179
TABLE 140 INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 180
TABLE 141 INDIA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 180
TABLE 142 INDIA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 143 INDIA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 144 AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 182
TABLE 145 AUSTRALIA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 146 AUSTRALIA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 147 AUSTRALIA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 148 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 184
TABLE 149 SOUTH KOREA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 150 SOUTH KOREA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 151 SOUTH KOREA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 185
TABLE 152 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 186
TABLE 153 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 154 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 155 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 156 LATIN AMERICA: KEY MACROINDICATORS 188
TABLE 157 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 188
TABLE 158 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 159 LATIN AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 160 LATIN AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 161 LATIN AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 190
TABLE 162 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 190
TABLE 163 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 191
TABLE 164 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 191
TABLE 165 BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 192
TABLE 166 BRAZIL: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 192
TABLE 167 BRAZIL: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 168 BRAZIL: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 169 MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 194
TABLE 170 MEXICO: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 171 MEXICO: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 172 MEXICO: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 173 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 196
TABLE 174 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 175 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 176 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING DYES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 177 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 198
TABLE 178 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY REGION,
2023–2030 (USD MILLION) 198
TABLE 179 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 199
TABLE 180 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 181 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 182 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 183 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 200
TABLE 184 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 201
TABLE 185 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 201
TABLE 186 GCC COUNTRIES: NEAR-INFRARED IMAGING MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 202
TABLE 187 GCC COUNTRIES: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 188 GCC COUNTRIES: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 189 GCC COUNTRIES: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 190 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 204
TABLE 191 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 192 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 193 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DYES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 194 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET 206
TABLE 195 NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION 209
TABLE 196 NEAR-INFRARED IMAGING MARKET: REGION FOOTPRINT 214
TABLE 197 NEAR-INFRARED IMAGING MARKET: PRODUCT FOOTPRINT 215
TABLE 198 NEAR-INFRARED IMAGING MARKET: PROCEDURE FOOTPRINT 216
TABLE 199 NEAR-INFRARED IMAGING MARKET: APPLICATION FOOTPRINT 217
TABLE 200 NEAR-INFRARED IMAGING MARKET: END-USER FOOTPRINT 218
TABLE 201 NEAR-INFRARED IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 221
TABLE 202 NEAR-INFRARED IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 222
TABLE 203 NEAR-INFRARED IMAGING MARKET: PRODUCT LAUNCHES,
JANUARY 2021–JULY 2025 225
TABLE 204 NEAR-INFRARED IMAGING MARKET: DEALS, JANUARY 2021–JULY 2025 226
TABLE 205 NEAR-INFRARED IMAGING MARKET: EXPANSIONS, JANUARY 2021–JULY 2025 227
TABLE 206 STRYKER: COMPANY OVERVIEW 228
TABLE 207 STRYKER: PRODUCTS OFFERED 229
TABLE 208 STRYKER: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 230
TABLE 209 STRYKER: DEALS, JANUARY 2021–JULY 2025 231
TABLE 210 CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW 232
TABLE 211 CARL ZEISS MEDITEC GROUP: PRODUCTS OFFERED 233
TABLE 212 CARL ZEISS MEDITEC GROUP: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 234
TABLE 213 CARL ZEISS MEDITEC GROUP: DEALS, JANUARY 2021–JULY 2025 234
TABLE 214 CARL ZEISS MEDITEC GROUP: EXPANSIONS, JANUARY 2021–JULY 2025 234
TABLE 215 PERKINELMER, INC.: COMPANY OVERVIEW 236
TABLE 216 PERKINELMER, INC.: PRODUCTS OFFERED 236
TABLE 217 PERKINELMER, INC.: EXPANSIONS, JANUARY 2021–JULY 2025 237
TABLE 218 OLYMPUS CORPORATION: COMPANY OVERVIEW 238
TABLE 219 OLYMPUS CORPORATION: PRODUCTS OFFERED 239
TABLE 220 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 240
TABLE 221 OLYMPUS CORPORATION: DEALS, JANUARY 2021–JULY 2025 240
TABLE 222 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–JULY 2025 240
TABLE 223 LEICA MICROSYSTEMS: COMPANY OVERVIEW 242
TABLE 224 LEICA MICROSYSTEMS: PRODUCTS OFFERED 243
TABLE 225 LEICA MICROSYSTEMS: DEALS, JANUARY 2021–JULY 2025 244
TABLE 226 LEICA MICROSYSTEMS: EXPANSIONS, JANUARY 2021–JULY 2025 244
TABLE 227 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 246
TABLE 228 KARL STORZ SE & CO. KG: PRODUCTS OFFERED 246
TABLE 229 SHIMADZU CORPORATION: COMPANY OVERVIEW 248
TABLE 230 SHIMADZU CORPORATION: PRODUCTS OFFERED 249
TABLE 231 SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 250
TABLE 232 SHIMADZU CORPORATION: DEALS, JANUARY 2021–JULY 2025 250
TABLE 233 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021–JULY 2025 250
TABLE 234 LI-COR BIOTECH, LLC: COMPANY OVERVIEW 251
TABLE 235 LI-COR BIOTECH, LLC: PRODUCTS OFFERED 251
TABLE 236 LI-COR BIOTECH, LLC: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 252
TABLE 237 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW 253
TABLE 238 HAMAMATSU PHOTONICS K.K.: PRODUCTS OFFERED 254
TABLE 239 HAMAMATSU PHOTONICS K.K.: EXPANSIONS, JANUARY 2021–JULY 2025 255
TABLE 240 QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW 256
TABLE 241 QUEST MEDICAL IMAGING B.V.: PRODUCTS OFFERED 256
TABLE 242 MERCK KGAA: COMPANY OVERVIEW 257
TABLE 243 MERCK KGAA: PRODUCTS OFFERED 258
TABLE 244 MERCK KGAA: EXPANSIONS, JANUARY 2021–JULY 2025 259
TABLE 245 MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW 260
TABLE 246 MIZUHO MEDICAL CO., LTD.: PRODUCTS OFFERED 260
TABLE 247 TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW 261
TABLE 248 TELEDYNE PRINCETON INSTRUMENTS: PRODUCTS OFFERED 262
TABLE 249 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 263
TABLE 250 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 264
TABLE 251 FLUOPTICS SAS: COMPANY OVERVIEW 265
TABLE 252 FLUOPTICS SAS: PRODUCTS OFFERED 265
TABLE 253 MEDTRONIC: COMPANY OVERVIEW 266
TABLE 254 MEDTRONIC: PRODUCTS OFFERED 266
TABLE 255 CAYMAN CHEMICAL: COMPANY OVERVIEW 267
TABLE 256 CAYMAN CHEMICAL: PRODUCTS OFFERED 267
TABLE 257 MP BIOMEDICALS: COMPANY OVERVIEW 268
TABLE 258 MP BIOMEDICALS: PRODUCTS OFFERED 268
TABLE 259 CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW 269
TABLE 260 CRYSTA-LYN CHEMICAL COMPANY: PRODUCTS OFFERED 269
TABLE 261 GOWERLABS LTD.: COMPANY OVERVIEW 270
TABLE 262 GOWERLABS LTD.: PRODUCTS OFFERED 270
TABLE 263 NIRX MEDICAL TECHNOLOGIES, LLC: COMPANY OVERVIEW 271
TABLE 264 EXOSENS (XENICS NV): COMPANY OVERVIEW 272
TABLE 265 BIOTIUM: COMPANY OVERVIEW 273
TABLE 266 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.: COMPANY OVERVIEW 274
TABLE 267 AAT BIOQUEST, INC.: COMPANY OVERVIEW 275
TABLE 268 OXFORD INSTRUMENTS: COMPANY OVERVIEW 276
TABLE 269 MOTHERSON: COMPANY OVERVIEW 277
TABLE 270 PHOTON ETC: COMPANY OVERVIEW 278
TABLE 271 SOTERIX MEDICAL INC.: COMPANY OVERVIEW 279
TABLE 272 KERNEL: COMPANY OVERVIEW 280
LIST OF FIGURES
FIGURE 1 NEAR-INFRARED IMAGING MARKET SEGMENTATION & REGIONAL SCOPE 29
FIGURE 2 NEAR-INFRARED IMAGING MARKET: RESEARCH DESIGN 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 38
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 7 NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH 42
FIGURE 8 NEAR-INFRARED IMAGING MARKET: CAGR PROJECTIONS 43
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
FIGURE 10 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 47
FIGURE 11 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE,
2025 VS. 2030 (USD MILLION) 48
FIGURE 12 NEAR-INFRARED IMAGING MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 49
FIGURE 13 NEAR-INFRARED IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET 51
FIGURE 15 RISING ADOPTION OF NEAR-INFRARED IMAGING IN SURGICAL AND DIAGNOSTIC APPLICATIONS DRIVING MARKET GROWTH 52
FIGURE 16 DEVICES SEGMENT HELD LARGEST SHARE OF MARKET IN 2O24 53
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 54
FIGURE 18 NORTH AMERICA TO CONTINUE TO DOMINATE NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD 55
FIGURE 19 NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 56
FIGURE 20 NEAR-INFRARED IMAGING MARKET: VALUE CHAIN ANALYSIS 73
FIGURE 21 NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS 74
FIGURE 22 NEAR-INFRARED IMAGING MARKET: ECOSYSTEM ANALYSIS 75
FIGURE 23 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 76
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEAR-INFRARED IMAGING PRODUCTS 78
FIGURE 25 KEY BUYING CRITERIA FOR NEAR-INFRARED IMAGING PRODUCTS 79
FIGURE 26 NEAR-INFRARED IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED IMAGING IN RECENT YEARS 82
FIGURE 27 NEAR-INFRARED IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED FLUORESCENCE IMAGING IN RECENT YEARS 83
FIGURE 28 NEAR-INFRARED DYES MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED FLUORESCENCE BIOLUMINESCENCE IMAGING IN RECENT YEARS 84
FIGURE 29 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS,
BY TYPE, 2024 (USD) 85
FIGURE 30 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS,
BY KEY PLAYER, 2024 (USD) 86
FIGURE 31 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS,
BY REGION, 2024 (USD) 87
FIGURE 32 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
FIGURE 33 NEAR-INFRARED IMAGING MARKET: NUMBER OF DEALS, BY KEY PLAYER,
2019–2023 (USD MILLION) 95
FIGURE 34 NEAR-INFRARED IMAGING MARKET: NUMBER OF INVESTOR DEALS,
BY KEY PLAYER, 2019–2023 (USD MILLION) 95
FIGURE 35 VALUE OF INVESTOR DEALS IN NEAR-INFRARED IMAGING MARKET,
BY KEY PLAYER, 2019–2023 (USD MILLION) 96
FIGURE 36 USE OF GEN AI IN NEAR-INFRARED IMAGING MARKET 98
FIGURE 37 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT 144
FIGURE 38 UK: NUMBER OF FLUOROSCOPY IMAGING ACTIVITIES (2023–2024) 163
FIGURE 39 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT 171
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN NEAR-INFRARED IMAGING
MARKET (2020−2024) 208
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET (2024) 209
FIGURE 42 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 212
FIGURE 43 NEAR-INFRARED IMAGING MARKET: COMPANY FOOTPRINT 213
FIGURE 44 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 220
FIGURE 45 EV/EBITDA OF KEY VENDORS 223
FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 223
FIGURE 47 NEAR-INFRARED IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 224
FIGURE 48 STRYKER: COMPANY SNAPSHOT (2024) 229
FIGURE 49 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2024) 233
FIGURE 50 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 239
FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 243
FIGURE 52 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 249
FIGURE 53 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2024) 254
FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2024) 258
FIGURE 55 TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2024) 262
FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 264
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11